Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1282 of 5804
-
Weekly insulin shot could replace daily injections for type 2 diabetes
Disease control OngoingThis study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Glargine U100 in Combination with Insulin Aspart (with or without Non-Insulin Antidiabetic Agents) in Subjects with Type 2 Diabetes Mellitus (T2DM)…
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Peer support after hospital stay may cut overdose and infection risk
Disease control Recruiting nowThe purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving …
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New pill aims to stall advanced prostate cancer when hormone drugs fail
Disease control Recruiting nowThe purpose of this clinical trial is to determine if GZ17-6.02 delays progression of castration-resistant prostate cancer.
Phase: PHASE1 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Dissolving stent could revolutionize treatment for long heart blockages
Disease control Recruiting nowThe study objective is the assessment of safety and clinical performance of Freesolve 35- and 40-mm in de novo coronary artery lesions up to 38 mm length.
Phase: NA • Sponsor: Biotronik AG • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug combo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis is an open label, multi-center, multiple dose Phase IB/II study to evaluate the safety, tolerability and efficacy of SHR-1826 for injection in subjects with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can remote exercise and weight loss boost heart failure Patients' stamina?
Symptom relief Recruiting nowHeart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercise intolerance (EI) is the cardinal symptom of HFpEF, which manifests as dyspnea …
Phase: PHASE2, PHASE3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New pill aims to slash hidden heart risk factor
Disease control CompletedThe main purpose of this study is to evaluate the efficacy and safety of HRS-5346 in adult participants with elevated Lp(a) at high risk for cardiovascular events.
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Phone buddies fight HIV: new study tests peer navigator app for young women in zambia
Prevention OngoingThe goal of this clinical trial is to learn if the TwySHE intervention can increase the use of HIV prevention in at-risk female university students aged 18-24 in Zambia. The main question it aims to answer is: • Can a mhealth peer navigator intervention effectively promote HIV p…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Heat-Sensing camera could speed up infection diagnosis in kids
Diagnosis Recruiting nowThis is a pilot proof of feasibility study to explore the efficacy of High Resolution Infrared Thermographic Imaging (HRTI) to assist with the detection of musculoskeletal infections in children. In HRTI, a sensitive thermal camera is used to capture the temperature profile of th…
Sponsor: Sheffield Children's NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Heavy lifting may help cancer survivors rebuild strength
Symptom relief Recruiting nowDespite improvements in treatments, head and neck cancer survivors (HNCS) still endure acute and chronic side effects such as loss of muscular strength, limitations in physical functioning, fatigue, and swallowing difficulties that impact quality of life (QoL) and limit return to…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Hope for women with essure implant symptoms: study tracks recovery after removal
Symptom relief Recruiting nowESSURE® is an implantable medical device for definitive and irreversible sterilization indicated for adult women of childbearing age. These implants are inserted into the fallopian tubes by hysteroscopy. Marketed in 2002, ESSURE® contraceptive implants were withdrawn from the Fre…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New therapy aims to break the cycle of addiction and family violence in fathers
Disease control Recruiting nowThis study involves a randomized controlled trial of Fathers for Change (F4C) compared to Individual Drug Counseling (IDC) with a sample of 280 fathers enrolled in substance use (SU) treatment within community or veterans (VA) healthcare settings to (a) demonstrate F4C efficacy c…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Weekly insulin shot could replace daily injections for diabetes
Disease control OngoingThis study will be conducted to compare the efficacy, safety and patient-reported outcome of once-weekly GZR4 and once-daily Insulin Glargine U100 with Non-Insulin Antidiabetic Agents in Insulin-naive Subjects with Type 2 Diabetes Mellitusin.
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New study aims to ease depression and anxiety in expecting and new mothers
Symptom relief Recruiting nowPerinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interv…
Phase: NA • Sponsor: Kenyatta National Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a Stop-Smoking pill tame dangerous heart rhythms?
Disease control CompletedThis is an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial designed to evaluate the preliminary efficacy of varenicline tartrate in patients with frequent PVCs complicated by myocardial infarction (MI). The protocol…
Phase: PHASE2 • Sponsor: Yihan Chen • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a cell injection free type 1 diabetics from insulin?
Disease control Recruiting nowThis Phase I clinical trial is a single-center, single-arm, open-label study aimed at evaluating the safety and therapeutic efficacy of RGB-5088 islet cell transplantation in patients with Type 1 Diabetes Mellitus.
Phase: PHASE1 • Sponsor: Hangzhou Reprogenix Bioscience, Inc • Aim: Disease control
Last updated Jun 26, 2026 17:21 UTC
-
New stomach bug treatment battle: which drug combo wins?
Disease control Recruiting nowThis study is a randomized, open-label, parallel-group clinical trial designed to compare two 14-day dual therapies for the eradication of Helicobacter pylori (H. pylori) infection. Participants will be randomly assigned to receive either tegoprazan 50 mg twice daily plus amoxici…
Phase: PHASE2, PHASE3 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to test the safety and efficacy of BMS-986482 alone and as combination therapy in participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Blood filtering showdown: can lower volume save young livers?
Disease control Recruiting nowAcute liver failure is a multisystem disorder characterized by a syndrome of jaundice, coagulopathy, and encephalopathy with high mortality in the absence of liver transplantation. The pathogenesis of multiorgan failure (MOF) in ALF has been attributed to the release of damage-as…
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New injection could ease back pain without surgery
Disease control Recruiting nowVIA Disc NP is a non-surgical intervention intended to supplement nucleus pulposus tissue in degenerated intervertebral discs. This is a randomized, sham-controlled, multi-center, double-blind clinical trial with an open label roll-in period of one participant per site in which …
Phase: NA • Sponsor: VIVEX Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC